Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma Journal Article


Authors: Wolchok, J. D.; Chiarion-Sileni, V.; Rutkowski, P.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Queirolo, P.; Dummer, R.; Butler, M. O.; Hill, A. G.; Postow, M. A.; Gaudy-Márqueste, C.; Lao, C. D.; Walker, J.; Márquez-Rodas, I.; Haanen, J. B. A. G.; Guidoboni, M.; Maio, M.; Carlino, M. S.; Sandhu, S.; Lebbé, C.; Ascierto, P. A.; Long, G. V.; Ritchings, C.; Nassar, A.; Askelson, M.; Benito, M. P.; Wang, W.; Hodi, F. S.; Larkin, J.; for the CheckMate 067 Investigators
Article Title: Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma
Journal Title: New England Journal of Medicine
Volume: 392
Issue: 1
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2025-01-02
Start Page: 11
End Page: 22
DOI: 10.1056/NEJMoa2407417
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PUBMED: 39282897
PMCID: PMC12080919
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    362 Postow